Active	Status	Sponsor type	Region	Phase	Filter
3 Active 2 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Dong, Jian
AZUR-2, NCT05855200: Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer	Recruiting	3	711	Europe, Canada, Japan, US, RoW	Dostarlimab, CAPEOX, FOLFOX	GlaxoSmithKline	Colonic Neoplasms, Neoplasms, Colon	12/28	12/30
China AZUR-1, NCT06640049: A Study of Dostarlimab in Participants With Untreated Locally Advanced Rectal Cancer in China	Recruiting	2	23	RoW	Dostarlimab, GSK4057190A, TSR-042	GlaxoSmithKline	Neoplasms, Rectal	12/28	03/31
NCT05450757: Shanghai ST-segment Elevation Myocardial Infarction Cohort	Recruiting	N/A	2000	RoW		Ruijin Hospital	ST Elevation Myocardial Infarction	09/23	09/24
Dong, Jiang
No trials found